PenderFund Capital Management Ltd. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PenderFund Capital Management Ltd. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,615,000
-48.4%
1,500,000
-50.0%
0.40%
-44.2%
Q4 2021$3,127,000
+7.3%
3,000,0000.0%0.71%
-6.7%
Q3 2021$2,913,000
-22.4%
3,000,0000.0%0.76%
-13.4%
Q2 2021$3,754,0003,000,0000.88%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,000,000$7,529,0003.08%
Context Capital Management, LLC 16,700$13,919,0000.90%
Opti Capital Management, LP 11,460,000$9,548,0000.77%
DeepCurrents Investment Group LLC 22,500,000$18,593,0000.58%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,050,000$24,245,0000.56%
PenderFund Capital Management Ltd. 1,500,000$1,615,0000.40%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$20,932,0000.27%
AQR Arbitrage LLC 9,900,000$8,388,0000.22%
CSS LLC/IL 5,000,000$4,154,0000.15%
Verition Fund Management LLC 6,313,000$5,349,0000.06%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders